|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS: | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| TOTAL CURRENT ASSETS | |||||||||||||||
| Deferred offering costs | |||||||||||||||
| Investments held in Trust Account | |||||||||||||||
| Prepaid expenses | |||||||||||||||
| TOTAL ASSETS | |||||||||||||||
| Accrued expenses | |||||||||||||||
| LIABILITIES: | |||||||||||||||
| Accrued expenses | |||||||||||||||
| TOTAL CURRENT LIABILITIES | |||||||||||||||
| Related party | |||||||||||||||
| Related Party | |||||||||||||||
| Total related party | |||||||||||||||
| Private warrant liability | |||||||||||||||
| TOTAL LIABILITIES | |||||||||||||||
| CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION: 515,019 shares at redemption value of $11.50 and $11.06 as of June 30, 2024 and December 31, 2023, respectively | |||||||||||||||
| CAPITAL DEFICIENCY: | |||||||||||||||
| Ordinary shares, value | |||||||||||||||
| Class A Ordinary Shares | |||||||||||||||
| Class B Ordinary Shares | |||||||||||||||
| Total ordinary shares, value | |||||||||||||||
| Class B Ordinary Shares, $0.0001 par value; 50,000,000 shares authorized, 2,875,000 issued and outstanding as of March 31, 2023 and December 31, 2022; | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| TOTAL CAPITAL DEFICIENCY | |||||||||||||||
| TOTAL LIABILITIES AND SHARES SUBJECT TO POSSIBLE REDEMPTION NET OF CAPITAL DEFICIENCY | |||||||||||||||
Loading...
